Publications
73
Citations
185
Est. group size
~41
Recurring co-author estimate
Active years
7
Publishing since 2020
Julia Chalif's research focuses on gynecologic cancers, including ovarian, endometrial, cervical, and vulvar/vaginal cancer, with particular attention to immunotherapy outcomes, treatment sequencing (such as PARP inhibitors and chemotherapy), and the role of the gut microbiome in cancer treatment response. The work also includes studies on how patients and clinical trials are represented on social media platforms like TikTok and Instagram, and on training and education for gynecologic oncology fellows.
Publication output was minimal before 2020 but has grown substantially since 2022, with a sharp increase from 2023 onward and sustained high yearly output through 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- From local pilot to national model: Expanding leadership training for gynecologic oncology fellows
Gynecologic Oncology · 2026
- Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer
Journal of Gynecologic Oncology · 2026
- Beyond the guidelines: Variation and outcomes of steroid tapering for ICI-related toxicities in gynecologic cancer
Gynecologic Oncology · 2026
- Benefit and cost: Early PARP inhibitor exposure shortens times to subsequent recurrences
Gynecologic Oncology · 2026
- Assessment of complete responses to immune checkpoint inhibitors by mismatch repair subtype in endometrial cancer
Gynecologic Oncology · 2026
- Real-world outcomes of immune checkpoint inhibitors in advanced and recurrent vulvar and vaginal cancer
Gynecologic Oncology · 2026
- Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility study
Gynecologic Oncology · 2026
- Evaluation of immunotherapy response in the radiated field in patients with recurrent endometrial and cervical cancer
Gynecologic Oncology · 2026
- Does prior radiation affect response? Assessment of tisotumab-vedotin activity in recurrent cervical cancer
Gynecologic Oncology · 2026
- Scrolling for science: Representation of gynecologic cancer clinical trials on instagram and TikTok
Gynecologic Oncology · 2026
- Clinical outcomes of immunotherapy retreatment in endometrial and cervical cancer
Gynecologic Oncology · 2026
- When one size doesn't fit all: Worse outcomes after immunotherapy in cervical adenocarcinoma
Gynecologic Oncology · 2026
- Neoadjuvant chemotherapy with and without immunotherapy in advanced endometrial cancer and the role of completion hysterectomy: A retrospective cohort analysis
Gynecologic Oncology · 2026
- Previvor perspectives – Engagement, content, and thematic differences between BRCA and Lynch syndrome posts on social media
Gynecologic Oncology · 2026
- TikTok as a window into parenting experiences of patients with gynecologic malignancies
Gynecologic Oncology · 2026
- Gynecologic Oncology×49
- International Journal of Gynecological Cancer×4
- Gynecologic Oncology Reports×4
- Obstetrics and Gynecology×2
- Obstetrical & Gynecological Survey×2
- Lisa M. Landrum
Medicine · Indiana University
- Kristin Bixel
Medicine · The Ohio State University
- Corinne Calo
Medicine · The Ohio State University
- Larry J. Copeland
Medicine · The Ohio State University
- Casey Cosgrove
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile